| Financial Year |
March 31 2020 |
| Monetary Funds |
4,608,846,552.89 |
| Held-for-trading Financial Assets |
63,000,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
27,172,863.87 |
| Advances to Suppliers |
-- |
| Other Receivables |
4,171,496.31 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
-- |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
23,702,661.45 |
| Total Current Assets |
4,726,893,574.52 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
431,292,127.92 |
| Under-construction Projects |
109,466,678.75 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
76,376,153.23 |
| R&D expenses |
-- |
| Goodwill |
3,895,328.16 |
| Long-Term Deferred and Prepaid Expenses |
31,446.46 |
| Deferred Income Tax Assets |
692,842.81 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
622,864,577.33 |
| Total Assets |
5,349,758,151.85 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
37,738,418.44 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
31,718,406.55 |
| Taxes Payable |
86,776,185.46 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
577,445,931.69 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
1,592,537,996.24 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
1,182,184.66 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
85,873,659.55 |
| Sub-Total of Non-Current Liabilities |
88,519,102.54 |
| Total Liabilities |
1,681,057,098.78 |
| Paid-In Capital(Or Share Stock) |
537,600,000.00 |
| Capital Surplus |
356,775,876.82 |
| Surplus Reserve |
360,815,351.25 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,388,179,017.46 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,668,701,053.07 |
| Owner's Equity（Stockholder's Equity） |
3,668,701,053.07 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,349,758,151.85 |
